Banner: Questions About BENLYSTA

FAQs

Racquel

Real patient
compensated by GSK

In a clinical study in Black patients with lupus, a reduction in disease activity was seen but was not statistically significant. Ask your doctor about BENLYSTA.

Frequently asked questions about lupus & BENLYSTA

Find answers to commonly asked questions about lupus and BENLYSTA (belimumab).

  • What are some common symptoms of lupus?

    Since SLE can affect many different parts of the body, it can cause a lot of different symptoms, and these symptoms may come and go. Also, symptoms may vary from one patient to the next.

    The most common signs and symptoms of lupus include fatigue (feeling tired often), fever, joint pain, stiffness and swelling, butterfly-shaped rash on the cheeks and bridge of the nose or rashes elsewhere on the body, sun sensitivity, fingers and toes that turn white or blue when exposed to cold or during stressful periods (Raynaud's phenomenon), shortness of breath, chest pain, dry eyes, headaches, and confusion and memory loss.

     

    BENLYSTA may not help with all of these symptoms. Talk to your healthcare provider to discuss your symptoms.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • What is SLE (systemic lupus erythematosus)?

    Systemic lupus erythematosus is a systemic autoimmune disease caused by your body's immune system attacking your own tissues and organs. Inflammation caused by lupus can affect many different body systems, including your joints, skin, kidneys, blood cells, brain, heart, and lungs.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • What is lupus nephritis (LN)?

    When lupus causes the immune system to attack and inflame your kidneys, it’s called "lupus nephritis." This inflammation can make your kidneys unable to properly remove waste from your blood or control the amount of fluids in your body.

    Lupus nephritis most often develops within 5 years after a lupus diagnosis. Talk to your doctor about the impact of lupus nephritis on your kidneys and strategies to monitor disease progression.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • Who can get lupus? Do only women have lupus?

    Anyone can get lupus, but about 9 out of 10 cases of lupus are in women ages 15 to 44.

    Lupus is more common in women of color (African American, Hispanic, Asian, and Native American and Alaskan Native women). Researchers think that genes play a role in how lupus affects minority women.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • What are the common symptoms of lupus nephritis?

    In the early stages of lupus nephritis, symptoms may not be apparent. If you see any of these common signs and symptoms, contact your doctor right away:

     

    • sudden and unexplained swelling, especially in the extremities (feet ankles, legs, fingers, arms) or the eyes
    • blood in the urine
    • elevated blood pressure
    • foamy or frothy urine
    • increased need to urinate, especially at night

     

    Please note that this is not a complete list of all possible lupus nephritis symptoms. BENLYSTA may not help with all of these symptoms. Talk to your healthcare provider to discuss your symptoms.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • Who can get lupus nephritis?

    Lupus nephritis most often develops within 5 years after your lupus diagnosis. Approximately 40% of people with lupus will develop lupus nephritis.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • If I have questions about taking BENLYSTA, whom can I talk to?

    You can ask your healthcare provider or pharmacist for information about BENLYSTA. Your BENLYSTA Cares support nurse* can also answer general questions about your treatment and provide you with additional resources to help with your lupus treatment.

     

    Call 1-877-4-BENLYSTA (1-877-423-6597), 8 am - 8 pm Eastern Time, Monday through Friday.

     

    *Nurses from BENLYSTA Cares do not give medical advice, and will direct you to your healthcare provider for any disease-, treatment-, or referral-related questions.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • What kind of medicine is BENLYSTA?

    BENLYSTA (belimumab) is a biologic therapy, not a steroid. It is taken in addition to your other lupus medications and is available in three options for adults with lupus and lupus nephritis:

    an autoinjector you self-inject

    a prefilled syringe you self-inject

    an intravenous (IV) infusion a healthcare provider administers

    For children ages 5 and above with lupus, BENLYSTA is available as an IV infusion.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • How does BENLYSTA work?

    In people with lupus, certain white blood cells called autoreactive B cells (cells that react against the body) stay in the body longer than they should.

    One of the important proteins for the growth of these B cells is called B-lymphocyte stimulator, or BLyS. BENLYSTA works by binding to BLyS. When BENLYSTA is attached to BLyS, BLyS can no longer bind to and stimulate the autoreactive B cells.

     

    Get more information on how BENLYSTA works

     

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • Who might be a candidate for treatment with BENLYSTA?

    BENLYSTA is not for everyone.

    Ask your doctor if BENLYSTA is right for you. Here are a few things you and your doctor may consider before prescribing BENLYSTA:

    • You have already been diagnosed with systemic lupus erythematosus (SLE) and/or lupus nephritis (LN).
    • You are currently taking medicines to help manage your lupus and/or lupus nephritis (LN).
    • Your lupus and/or lupus nephritis (LN) has continued to be active. 

     

    Remember, only you and your doctor can decide whether BENLYSTA is right for you.

     

    Other information to consider
    • It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

     

    BENLYSTA and pregnancy
    • Before you receive BENLYSTA, tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known if BENLYSTA will harm your unborn baby.
    • You should talk to your healthcare provider about whether to prevent pregnancy while on BENLYSTA. If you choose to prevent pregnancy, you should use an effective method of birth control while receiving BENLYSTA and for at least 4 months after the final dose of BENLYSTA.
    Tell your healthcare provider right away if you become pregnant during your treatment with BENLYSTA or if you think you may be pregnant.
    • If you become pregnant while receiving BENLYSTA, talk to your healthcare provider about enrolling in the BENLYSTA Pregnancy Registry. You can enroll in this registry by calling 1-877-681-6296. The purpose of the registry is to monitor the health of you and your baby.
    • Tell your healthcare provider if you are breastfeeding or plan to breastfeed. It is not known if BENLYSTA passes into your breast milk. You and your healthcare provider should decide if you will receive BENLYSTA and breastfeed.

     

    This is not the full list of the things your healthcare professional will need to consider before prescribing BENLYSTA. For more information, refer to the Medication Guide for BENLYSTA and talk to your doctor.

     

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • I’m currently receiving monthly BENLYSTA IV infusions. Can I switch to the autoinjector?

    You may be a candidate for BENLYSTA at-home administration with the autoinjector. Talk to your doctor to see if switching to the BENLYSTA autoinjector is right for you.

     

    If you and your doctor decide that you should switch, BENLYSTA Gateway is there to help you through the process.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • Can I take BENLYSTA if I am pregnant or plan to become pregnant?

    Before you receive BENLYSTA, tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known if BENLYSTA will harm your unborn baby.

    • You should talk to your healthcare provider about whether to prevent pregnancy while on BENLYSTA. If you choose to prevent pregnancy, you should use an effective method of birth control while receiving BENLYSTA and for at least 4 months after the final dose of BENLYSTA.

    Tell your healthcare provider right away if you become pregnant during your treatment with BENLYSTA or if you think you may be pregnant.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • What is the most important information I should know about BENLYSTA?

    Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these side effects may cause death. Please see Prescribing Information and Medication Guide for BENLYSTA.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • Can I stop taking my other medicines while on BENLYSTA?

    Talk to your doctor. You should not make any changes in your medication regimen without first consulting your doctor. BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. BENLYSTA IV is approved in children aged 5 years and older with SLE on other lupus medicines. It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • Is BENLYSTA a steroid?

    BENLYSTA is a biologic therapy, not a steroid. It's the only FDA-approved treatment that targets BLyS, an underlying cause of lupus.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • How is BENLYSTA administered?

    For children ages 5 and above and adults, BENLYSTA can be administered by your healthcare provider through an IV infusion

    For adults, BENLYSTA can also be self-injected once a week through a subcutaneous (SC) injection, either with an autoinjector or a prefilled syringe.

    Learn more about dosing for BENLYSTA.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • How many patients were included in the clinical trials for BENLYSTA?

    BENLYSTA has the largest lupus clinical trial program to date.  BENLYSTA has been studied in multiple lupus clinical trials involving more than 2,500 adult patients, over 1,100 of whom were treated with BENLYSTA. To date, the pediatric program has included 93 children with lupus. BENLYSTA was also studied in the largest and longest lupus nephritis clinical trial ever conducted, which involved 448 adult patients.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • What are the most common side effects of BENLYSTA?

    The most common side effects of BENLYSTA are nausea, diarrhea, fever, stuffy or runny nose and sore throat, persistent cough, trouble sleeping, leg or arm pain, depression, headache, pain, redness, itching, or swelling at the site of injection (when given subcutaneously).

     

    These are not all the possible side effects of BENLYSTA. Talk to your healthcare provider for medical advice about side effects.

     

    Risks and side effects

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • Can BENLYSTA have serious side effects?

    Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these side effects may cause death.

    • Infections
      Infections could be serious, leading to hospitalization or death.
    • Allergic (hypersensitivity) reactions
      Serious allergic reactions can happen on the day of, or in the days after, receiving BENLYSTA and may cause death. Tell your healthcare provider right away if you have any symptoms of an allergic reaction.
    • Mental health problems and suicide
    • Progressive multifocal leukoencephalopathy (PML): PML is a serious and life-threatening brain infection. Your chance of getting PML may be higher if you are treated with medicines that weaken your immune system, including BENLYSTA. PML can result in death or severe disability. If you notice any new or worsening medical problems such as those below, tell your healthcare provider right away: memory loss; trouble thinking; dizziness or loss of balance; difficulty talking or walking; loss of vision.
    • Cancer
       

    Please see Prescribing Information and Medication Guide for BENLYSTA for additional information.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • Is BENLYSTA chemotherapy?

    No, BENLYSTA is not chemotherapy – it's a biologic therapy, delivered either through an intravenous (IV) infusion or as a subcutaneous (SC) self-injection. It works by reducing certain cells in your immune system that can make lupus active.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • Will my insurance or Medicare cover the cost of BENLYSTA?

    Each insurance policy is different and costs depend on your individual plan.

    To understand your cost for BENLYSTA, contact your insurance company or call BENLYSTA Cares at 1-877-4-BENLYSTA (1-877-423-6597). BENLYSTA Cares will connect you with BENLYSTA Gateway, who can research your estimated cost for BENLYSTA under your insurance policy.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • What is the BENLYSTA Co-pay Program?

    The BENLYSTA Co-Pay Program helps eligible approved patients with their out-of-pocket costs for BENLYSTA up to $15,000 for 12 months.

    If approved, patients could pay as little as $0 for BENLYSTA.

    Patients in government-funded programs (eg, Medicare, Medicaid, VA, or TRICARE) are not eligible for the BENLYSTA Co-pay Program. Medicare-eligible patients who are enrolled in certain retiree drug benefit plans are also ineligible for the co-pay program. (Most patients become eligible for Medicare when they reach age 65.)

    Patients must submit an Enrollment Form or complete eligibility check online at www.BenlystaCopayProgram.com so their eligibility can be determined.

    Click here for full Program Terms & Conditions.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • Who is eligible for the BENLYSTA Co-pay Program?

    You may be eligible for the program if:

    • You have a commercial medical or prescription insurance plan; or you are uninsured
    • You are a resident of the US (including the District of Columbia, Puerto Rico and the US Virgin Islands)

    You are not eligible for the program if:

    • You have a state or federal government-funded medical or prescription insurance plan such as Medicare, Medicaid, VA, or TRICARE.  Medicare-eligible patients who are enrolled in certain retiree drug benefit plans are also ineligible for the co-pay program. (Most patients become eligible for Medicare when they reach age 65)
    • You are enrolled in a commercial health plan that does not permit the use of co-pay assistance programs

     

    Click here for full Program Terms & Conditions.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.